Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2018 250 378 M
EBIT 2018 -
Net income 2018 38 584 M
Finance 2018 133 687 M
Yield 2018 2,09%
Sales 2019 273 047 M
EBIT 2019 -
Net income 2019 44 895 M
Finance 2019 143 609 M
Yield 2019 2,16%
P/E ratio 2018 30,89
P/E ratio 2019 24,96
EV / Sales2018 4,71x
EV / Sales2019 4,28x
Capitalization 1 313 139 M
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
08/16 ONO PHARMACEUTICAL : Opdivo® (Nivolumab) Intravenous Infusion Approved for Suppl..
08/16 ONO PHARMACEUTICAL : Bristol-Myers Squibb Announces Topline Results from CheckMa..
08/03 ONO PHARMACEUTICAL : Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivo..
07/20 ONO PHARMACEUTICAL : Patent Issued for Therapeutic Agent for Autoimmune Diseases..
07/18 ONO PHARMACEUTICAL : Support for Relief Efforts to the Northern Kyushu Heavy Rai..
07/14 ONO PHARMACEUTICAL : Notice Concerning Determination of Details of Issuance of S..
07/13 ONO PHARMACEUTICAL : Second Phase III Study Shows Kyprolis® (Carfilzomib) Regime..
07/06 ONO PHARMACEUTICAL : Array BioPharma Submits New Drug Applications to FDA for Bi..
07/06 ONO PHARMACEUTICAL : Phase 3 Study Evaluating the Safety and Efficacy of Adjuvan..
06/29 ONO PHARMACEUTICAL : Patent Issued for Left Ventricular Diastolic Function Impro..
More news
Sector news : Generic Pharmaceuticals
08/18DJCorrection to Biogen Treads Tricky Path Between Politicians, Investors Articl..
08/18DJMERCK AND : Scientists, Out $12 Million, Sue Delaware Over Seizure of Their Stoc..
08/18DJASTRAZENECA : FDA Approves AstraZeneca's Ovarian Cancer Treatment Lynparza Table..
08/17 FDA expands use of AstraZeneca/Merck ovarian cancer drug
08/17 Drugmaker Hikma trims sales forecasts, shares fall
More sector news : Generic Pharmaceuticals
Latest Tweets
06/29ONO PHARMACEUTICAL : Notice of Resolutions Passed at The 69th Ordinary Genera.. 
06/29ONO PHARMACEUTICAL : Notice Concerning Issuance of Stock Options (Stock Acqui.. 
06/13ONO PHARMACEUTICAL : Announcement on Acquisition and Retirement of Own Shares.. 
05/31$ARRY (+3.1% pre) Array BioPharma & Ono Pharmaceutical Announce A License..
2
05/31BRIEF-Ono Pharmaceutical concludes a license agreement with array biopharma r.. 
More tweets
Qtime:24
News from SeekingAlpha
06/22 Only Bristol Bucks Big Pharma's Drive For External Reliance
06/02 3 THINGS IN BIOTECH YOU SHOULD LEARN : June 2, 2017
05/31 Array out-licenses binimetinib and encorafenib to Ono Pharma for Japan and So..
05/10 BRISTOL-MYERS SQUIBB : A Deep Dive Finds Some Pearls
01/23 Bristol Catches A Break At Last
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Technical analysis trends ONO PHARMACEUTICAL CO., LT
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 2 665  JPY
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Shozo Matsuoka Executive Officer & Manager-Medical Affairs
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director, EVP & General Manager-Development
Isao Ono Director & Managing Executive Officer
Sector and Competitors